- Home
- BBNX
BBNX
Beta Bionics Inc.
as of 08-13-2026 4:00pm EST
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 493.1M | IPO Year: | 2025 |
| Target Price: | $23.80 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.02 | EPS Growth: | 78.95 |
| 52 Week Low/High: | $8.80 - $32.71 | Next Earning Date: | 04-21-2026 |
| Revenue: | $100,251,000 | Revenue Growth: | 53.94% |
| Revenue Growth (this year): | 34.9% | Revenue Growth (next year): | 34.63% |
| P/E Ratio: | -16.99 | Index: | N/A |
| Free Cash Flow: | -56222000.0 | FCF Growth: | N/A |
Compare BBNX vs Leading Stocks
See how BBNX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "BBNX Beta Bionics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.